로딩 중…
지수 로딩 중…
Viridian Therapeutics, Inc.
VRDN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$16.63-0.48%
2026-06-18
Price Chart
Viridian Therapeutics, Inc.+10.87%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.84B |
| Revenue | $71M |
| Net Income | $-361M |
| Total Assets | $789M |
| Net Assets | $636M |
| Value | |
| P/B | 2.89x |
| P/S | 25.89x |
| FCF Yield | -16.54% |
| Profitability | |
| ROE | -56.70% |
| ROA | -45.70% |
| Op. Margin | -543.86% |
| Revenue Growth | 95.83% |
| Financial Health | |
| Debt Ratio | 24.06% |
| Total Debt | $51M |
| FCF | $-304M |
| Cash | $176M |
| Current Ratio | 15.15x |
| Performance | |
| 1Y Return | 10.87% |
| 1M Return | 4.13% |
| From 52W High | -51.50% |
| 1Y MDD | -60.63% |
| Trading | |
| Volume | 3,015,294 shares |
| Trading Value | $51M |
| Per Share | |
| EPS | $-4.04 |
| BPS | $8.52 |